Smith & Nephew (SN.)
09/01/2018 - 16:34 RNS
RNS Number: 4057B Smith & Nephew Plc 09 January 2018 SMITH & NEPHEW PLC 9 January 2018 NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLO...
09/01/2018 - 14:37 RNS
RNS Number: 3927B Smith & Nephew Plc 09 January 2018 Timing of Smith & Nephew full year results 9 th January 2018 Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, will announce its results for the full year ended 31 st December 2017 on Thursday, 8 th February 2018 at 7:00am GMT / 2:00am EST. This will be followed by a con...
04/01/2018 - 16:03 RNS
RNS Number: 0228B Smith & Nephew Plc 04 January 2018 4 January 2018 Smith & Nephew plc DIRECTOR DECLARATION In accordance with Listing Rule 9.6.14 R the Company announces that Vinita Bali, Non-Executive Director of Smith & Nephew plc, has been appointed as Non-Executive Director of Bunge Limited with effect from 3 January 2018. Bunge L...
02/01/2018 - 14:33 RNS
RNS Number: 7467A Smith & Nephew Plc 02 January 2018 2 January 2018 Smith & Nephew plc (the "Company") Voting Rights and Capital In conformity with Rule 5.6 of the FCA's Disclosure and Transparency Rules:- The total issued share capital of Smith & Nephew plc as at 31 December 2017 comprises 890,855,310 Ordinary Shares of US20 each ("Ordinary Share...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment